Bivalent VHH Manufacturing

• 

  Efficient production of bivalent VHH for therapeutic use

  At Yaohai, what we want to do is make good cures for real patients. So we created a really nice production method for bivalent VHH to use them in therapy. Bivalent VHH molecules were customized to identify proteins responsible for causing various disease states in the human system. Our bivalent VHH molecules by targeting these proteins can alleviate the symptoms associated with these maladies and bring about a much-needed improvement in the lives of many patients out there end for each.

  
  

• 

  Customizable bivalent VHH manufacturing for personalized medicine

  One of the advantages of bivalent VHH molecules is that these can be programmed to achieve specificity for particular proteins within the body. We can, therefore, tailor medicine for individual patients and designed specifically to help that patient with their own health problems. At Yaohai, we have designed a novel approach to produce Bivalent VHH that can be used for many diseases.

  
  

• 

  Revolutionizing biologics with bivalent VHH production methods

  With the development of our bivalent VHH production, biologics are about to change for the better at Yaohai. Our Novel Method of Yaohai 3-Valent VHH Production well as the capability to produce and manufacture them for therapeutic purposes, which are adapted with a personalized medicine that is made to improve patient quality of life and help many ill people.

  
  

Why choose Yaohai Bivalent VHH Manufacturing?

• Customization, Efficiency & Cost-Effectiveness

  Yaohai Bio-Pharma is experienced in the development of microbial-derived biologics. We offer customized RD as well as manufacturing solutions, while making sure that there are no risks. We have worked on diverse modalities such as subunit-based recombinant vaccines, Bivalent VHH Manufacturing, cytokines, growth factors, single domain antibodies, enzymes, plasmid DNA, the mRNA, and other. We are experts in a variety of microorganisms, including yeast extracellular and intracellular secretion (yields up to 15g/L) as well as bacteria intracellular soluble and inclusion body (yields as high as 10g/L). We have also developed the BSL-2 fermentation platform to create bacteria-based vaccines. We have a track record of improving production processes, thereby increasing yields and decreasing costs. With a highly efficient technology team, we ensure timely and quality project delivery and bring your products to market faster.

• Quality System & Global Regulatory Compliance

  Bivalent VHH Manufacturing is a Top 10 Microbial CDMO that incorporates quality control and regulatory matters. We have established a robust quality system that complies with the current GMP standards and regulations all over the world. Our regulatory team is well-versed on global regulatory frameworks to speed up biological launches. We guarantee traceable production processes and top-quality products that are compliant with the rules of US FDA, EU EMA, Australia TGA, and China NMPA. Yaohai BioPharma successfully passed an audit on site conducted by an accredited Qualified Person from the European Union (QP) to review our GMP system and production facility. Additionally, we've passed the first certification audits of the ISO9001 Quality Management System, ISO14001 Environmental Management System, and ISO45001 Occupational Health and Safety Management System.

• Professional Expertise & Extensive Experience

  Yaohai Bio-Pharma is a leading in microbial biologics CDMO. Our primary focus is the production of microbial vaccinations and therapeutics for managing pets, human and Bivalent VHH Manufacturing. We are equipped with cutting-edge RD platforms as well as manufacturing technologies that encompass the entire process beginning with the development of microbial strains and cell banking, to method and process development, to clinical and commercial manufacture that ensures the successful supply of new solutions. Through the years, we have accumulated vast knowledge of microbial-based bio processing. Over 200 projects have been successfully completed and we assist our clients to get through regulations, such as those of the US FDA and EU EMA. We also assist them in navigating Australia TGA and China NMPA. We are able respond promptly to market demands and offer tailored CDMO services thanks to our experience and expertise.

• Robust Supply Chain & Manufacturing Capabilities

  Yaohai Bio-Pharma, a top 10 manufacturer of biological products, specializes in microbial fermentation. We have created a Bivalent VHH Manufacturing manufacturing facility with robust RD capabilities and cutting-edge manufacturing facilities. Five drug substance production lines conforming to GMP standards to purify and ferment microbial cells, as well as two fill and finish lines for vials and cartridges, as well as needles that are pre-filled, are available. The available fermentation scales include 100L, 500L, 1000L and 2000L. Specifications for filling vials range from 1ml - 25ml. the pre-filled cartridge or syringe filling specifications range from between 1-3ml. The production workshop is cGMP-compliant and provides a stable supply of commercial products and clinical samples. Our facility produces large molecules that are shipped worldwide.

Related product categories

• AAV Plasmid Manufacturing
• Analytical Methods for Plasmid DNA
• Bacteriophage AP205 VLP Manufacturing
• Bacteriophage Q VLP Manufacturing
• Chimeric VLP Vaccine Manufacturing
• Conjugate VLP Vaccines Manufacturing
• DNA Vaccine Manufacturing
• E. coli Fermentation for VLP Production
• GLP-1 Agonist Manufacturing
• GLP-1 Analog Manufacturing

Not finding what you're looking for?
Contact our consultants for more available products.